Company: GAUZ
Filing Date: 2025-03-11
Form Type: 20-F
Source: 0001213900-25-022437
Chunk: 73

Company: Gauzy Ltd.
Filing Date: 2025-03-11
Form: 20-F
Item: Item 5
Chunk 73
---
 by approximately $0.8 million, or 2.5%, to approximately $31.9 million for the year ended December 31, 2024, compared
to approximately $31.1 million for the year ended December 31, 2023. The increase resulted mainly from a decrease of $26.1 million in
net loss, offset by a decrease of $26.3 million in non-cash financial expenses and valuation of marketable shares. An additional increase
resulted from an increase of $4.0 million in share-based compensation and an increase of $1.3 million in deferred revenues and trade
receivable, offset by an increase in payment of earn-out and earn-out revaluation in the amount of $3.4 million, a decrease of $1.6 million
in trade payable and accrued expenses and a decrease of $1.1 million in inventory.

Net cash used in investing activities

Net cash used in investing activities increased
by $0.8 million or 7.8%, to approximately $11.4 million for the year ended December 31, 2024, compared to $10.6 million for the year
ended December 31, 2023. This increase was mainly due to purchases of property, plant and equipment in the amount of $5.7 million, offset
by a decrease of $4.5 million from the purchase of IP related to the REC Agreement with Resonac.

Net cash provided by financing activities

Net cash provided by financing
activities increased by $2.9 million, or 6.9%, to approximately $44.6 million for the year ended December 31, 2024, compared to $41.7
million for the year ended December 31, 2023. This increase was mainly due to the receipt of proceeds from our initial public offering
in June 2024, net of offering costs, in the amount of $66.3 million and an increase in proceeds from long-term debt measured under the
fair value option in the amount of $9.4 million and an increase in changes in factoring loans in the amount of $1.7 million, offset by
an increase in payments of long-term debt measured under the fair value option in the amount of $54.3 million, a decrease in proceeds
from issuance of convertible loans in the amount of $15.5 million, an increase in settlement of phantom warrants in the amount of $2.8
million, and a